A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants
Clinical trial NCT05632211 · COMPLETED
Trial details
- NCT number
- NCT05632211
- Sponsor
- Alvotech Swiss AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-16
- Primary completion
- 2023-10-03
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.